Tuesday, Ardea Biosciences Inc. (RDEA) appointed Felix Baker to its board. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder.
Ardea Biosciences Inc., a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout, human immunodeficiency virus, cancer, and inflammatory diseases in the United States.
For comments and feedback: editorial@rttnews.com